Belzutifan is an inhibitor of HIF-2α. It’s used to treat RCC linked to VHL and helps cut down on tumor hypoxia. You can get it as 40 mg film-coated tablets.
The usual dose is 120 mg, taken just once a day. The drug comes in bottles with 90 tablets each. Belzutifan is mainly used to tackle the low-oxygen parts of tumors, which are signs of RCC linked to von Hippel-Lindau syndrome.
How you take it and the dose are super important for it to work. The standard dose is 120 mg a day. The tablets are coated so they’re easy to swallow and get absorbed in your body.
Reviews
There are no reviews yet.